These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20215497)

  • 21. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K; Kokkoli E
    Langmuir; 2012 Mar; 28(10):4729-36. PubMed ID: 22268611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor.
    He X; Na MH; Kim JS; Lee GY; Park JY; Hoffman AS; Nam JO; Han SE; Sim GY; Oh YK; Kim IS; Lee BH
    Mol Pharm; 2011 Apr; 8(2):430-8. PubMed ID: 21222482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A diaCEST MRI approach for monitoring liposomal accumulation in tumors.
    Chan KW; Yu T; Qiao Y; Liu Q; Yang M; Patel H; Liu G; Kinzler KW; Vogelstein B; Bulte JW; van Zijl PC; Hanes J; Zhou S; McMahon MT
    J Control Release; 2014 Apr; 180():51-9. PubMed ID: 24548481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.
    Kneepkens E; Fernandes A; Nicolay K; Grüll H
    Invest Radiol; 2016 Nov; 51(11):735-745. PubMed ID: 27309776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
    Kuo PH; Teng YH; Cin AL; Han W; Huang PW; Wang LH; Chou YT; Yang JL; Tseng YL; Kao M; Chang MD
    Drug Deliv; 2020 Dec; 27(1):542-555. PubMed ID: 32241176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe.
    Geninatti Crich S; Bussolati B; Tei L; Grange C; Esposito G; Lanzardo S; Camussi G; Aime S
    Cancer Res; 2006 Sep; 66(18):9196-201. PubMed ID: 16982763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin.
    Gottlieb JJ; Washenik K; Chachoua A; Friedman-Kien A
    Lancet; 1997 Nov; 350(9088):1363-4. PubMed ID: 9365453
    [No Abstract]   [Full Text] [Related]  

  • 29. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
    Ponce AM; Viglianti BL; Yu D; Yarmolenko PS; Michelich CR; Woo J; Bally MB; Dewhirst MW
    J Natl Cancer Inst; 2007 Jan; 99(1):53-63. PubMed ID: 17202113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.
    Ren L; Chen S; Li H; Zhang Z; Ye C; Liu M; Zhou X
    Nanoscale; 2015 Aug; 7(30):12843-50. PubMed ID: 26022345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q
    Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
    Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients.
    La-Beck NM; Zamboni BA; Gabizon A; Schmeeda H; Amantea M; Gehrig PA; Zamboni WC
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):43-50. PubMed ID: 21590446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
    Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
    Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging.
    Saito R; Bringas JR; McKnight TR; Wendland MF; Mamot C; Drummond DC; Kirpotin DB; Park JW; Berger MS; Bankiewicz KS
    Cancer Res; 2004 Apr; 64(7):2572-9. PubMed ID: 15059914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ dose amplification by apoptosis-targeted drug delivery.
    Wang K; Na MH; Hoffman AS; Shim G; Han SE; Oh YK; Kwon IC; Kim IS; Lee BH
    J Control Release; 2011 Sep; 154(3):214-7. PubMed ID: 21763738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging.
    Li S; Goins B; Zhang L; Bao A
    Bioconjug Chem; 2012 Jun; 23(6):1322-32. PubMed ID: 22577859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.